CRISPR News 🧬
@CRISPR_News
The latest CRISPR breakthroughs @crispr-news.bsky.social
Researchers at @Stanford have developed CRISPR-TO, a new tech acting like an "RNA mailman" to precisely target damaged neurons. This could offer new hope for ALS & spinal injuries by promoting nerve cell repair. #CRISPR #Neuroscience news.stanford.edu/stories/2025/0…
CRISPR zeroes in on SDR42E1—a gene that supercharges vitamin D uptake and cripples colorectal cancer cells. 🔬☀️ #CRISPR #VitaminD digitaljournal.com/tech-science/c…
Big news! The Chan Zuckerberg Initiative & Innovative Genomics Institute have launched the Center for Pediatric CRISPR Cures to develop personalized gene-editing treatments for kids with rare genetic diseases. 🌍🔬 More info: chanzuckerberg.com/newsroom/cente…
Baby KJ, the world's first patient to receive personalized CRISPR gene editing therapy for a rare metabolic disease, is now home and thriving! This groundbreaking treatment offers hope for other untreatable genetic conditions. #CRISPR #GeneEditing yahoo.com/news/worlds-fi…
Researchers at the University of Bayreuth have used CRISPR-Cas9 to create spiders that produce red fluorescent silk. This breakthrough could revolutionize materials science by enhancing silk's natural strength & elasticity. #Science #Biotech newatlas.com/biology/worlds…
Amazing news! 🌟 Baby KJ received a custom CRISPR therapy for a life-threatening genetic disorder, developed in a record 6 months! He's now thriving, and this breakthrough could revolutionize personalized medicine. A true game-changer! 🧬 #CRISPR wired.com/story/a-baby-r…
CRISPR is revolutionizing cancer treatment! 💥 Researchers used CRISPR to eliminate 50% of head & neck tumors in mice by targeting the SOX2 gene. Read more about this groundbreaking study: insideprecisionmedicine.com/topics/oncolog… #CRISPR #CancerResearch #GeneEditing
Johns Hopkins & Cold Spring Harbor scientists use CGISPR to boost tomato & eggplant size, enhancing flavor and yields. technologynetworks.com/applied-scienc…
Bahrain makes history as the first country outside the US to successfully treat sickle cell disease using #CRISPR-based gene-editing therapy, Casgevy. @CRISPRTX morningstar.com/news/globe-new…
England's NHS approves a groundbreaking gene therapy for sickle cell disease, offering new hope to thousands. Know as Exa-cel or Casgevy and developed by @CRISPRTX and @VertexPharma theguardian.com/society/2025/j… #Healthcare #Innovation #SickleCellDisease #GeneTherapy 🧬
NEW TREATMENT APPROVED FOR SICKLE CELL! We are delighted that NICE has today approved the groundbreaking gene therapy, Exa-cel, or Casgevy, for use through the NHS in people living with sickle cell disorder. Our CEO John James OBE comments here.